Preferred Label : FOLFOX-Encorafenib/Panitumumab Regimen;
NCIt synonyms : Folinic Acid/Fluorouracil/Oxaliplatin/Encorafenib/Panitumumab Regimen; FOLFOX-Panitumumab/Encorafenib; FOLFOX-Encorafenib-Panitumumab; Leucovorin/Fluorouracil/Oxaliplatin/Encorafenib/Panitumumab; Leucovorin-Fluorouracil-Oxaliplatin-Encorafenib-Panitumumab; FOLFOX Plus Panitumumab/Encorafenib; FOLFOX Plus Encorafenib/Panitumumab; Encorafenib/Fluorouracil/Leucovorin/Oxaliplatin/Panitumumab; FOLFOX Plus Braftovi-Vectibix; Encorafenib/Panitumumab Plus FOLFOX; Panitumumab/Encorafenib Plus FOLFOX; Encorafenib-Panitumumab-FOLFOX; Panitumumab/Encorafenib-FOLFOX; FOLFOX- Vectibix/Braftovi; FOLFOX/Panitumumab/Encorafenib; FOLFOX/Encorafenib/Panitumumab;
NCIt definition : A regimen consisting of leucovorin, fluorouracil and oxaliplatin (FOLFOX) plus encorafenib
and panitumumab that is used for the treatment of colorectal cancer.;
Origin ID : C215162;
chemotherapy_regimen_has_component
- concept_is_in_subset
- regimen_has_accepted_use_for_disease
